Aurora Diagnostics Acquires Cleveland Skin Pathology Laboratory
News May 16, 2017
Aurora Diagnostics has announced the acquisition of Cleveland Skin Pathology Laboratory Inc.
Founded in 1972, Cleveland Skin Pathology Laboratory is a physician-owned medical practice providing dermatopathology services to dermatologists, surgeons, and primary care providers, with concentration in the Midwest but with coast-to-coast reach. The practice has six board-certified dermatopathologists, who are also board-certified in pathology or dermatology. All of the doctors are committed academicians actively engaged within their specialty areas.
“We are very pleased to welcome the highly respected Cleveland Skin Pathology Laboratory team to our growing family of pathology practices,” said Daniel D. Crowley, President, Chairman and CEO of Aurora Diagnostics. “Their history of working in a collaborative environment and being available to discuss cases with referring clinicians is an approach that we appreciate and encourage at Aurora Diagnostics.”
“We are all excited to be part of the Aurora Diagnostics team” said Jonathan Bass, MD, President of Cleveland Skin Pathology. “Aurora is an excellent cultural fit, with its commitment to community-based pathology practices. In addition, the company brings valuable resources dedicated to information technology, payor relations, human resources, and purchasing. We look forward to working with a team of committed colleagues and providing many more decades of diagnostic excellence to the physicians and patients we serve.”
Terms of the transaction were not disclosed.
Tweak to Technique Could Bolster Disease DetectionNews
A team of Stanford researchers has developed a technique that they hope could more precisely detect diseases or disorders such as cancer or a heart attack.READ MORE
Newly Found Metabolic Zika Pathway Involved in NeurogenesisNews
A new study has highlighted molecules that may be key to the Zika virus's ability to evade the body's safeguards and cause brain damage.READ MORE
New Preservation Method Maintains Viable CTCs for up to 72 HoursNews
A new blood stabilization method significantly prolongs the lifespan of blood samples for microfluidic sorting and transcriptome profiling of rare circulating tumor cells.READ MORE